COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Treatment of Autistic Children Using NAET Procedures

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00277407
Recruitment Status : Completed
First Posted : January 16, 2006
Last Update Posted : May 7, 2007
Information provided by:
Nambudripad's Allergy Research Foundation

Brief Summary:
  1. Purpose of this study is to determine whether NAET procedures are effective in the treatment of children with allergy-related autism spectrum disorders in restoring their verbal and nonverbal communication.
  2. Hypothesis: Children in the experimental group will show a significant improvement over the control group in verbal and nonverbal communication as most food allergen groups, environmental allergen groups, childhood immunizations, and some other relevant allergenic substances are desensitized in a systematic way using NAET® procedures within the specified period of study.

Condition or disease Intervention/treatment Phase
Autism Food Allergies Procedure: NAET with acupressure and/or chiropractic procedures Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Investigation Into the Outcome of NAET Treatment on Children With Allergy-Related Autism Spectrum Disorders in a Multi-Clinical Setting.
Study Start Date : June 2006
Actual Study Completion Date : May 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Allergy

Primary Outcome Measures :
  1. Improvement in verbal and norverbal communication [ Time Frame: Twenty-four months from the starting date (approximately may 2008) ]

Secondary Outcome Measures :
  1. Reduction of commonly seen autistic traits [ Time Frame: Twenty-four months from starting dat (May 2008) ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   3 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

all subjects (control and treatment group) should demonstrate typical autistic symptoms before beginning NAET® treatments: made no eye contact, unable to communicate verbally or nonverbally. All subjects should bring in a proof of established diagnosis of autism spectrum disorder by a conventional physician.


Exclusion Criteria:

Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Any patient who has any of the following conditions will also be disqualified.

  1. Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc.
  2. Any type of cancer
  3. Aids
  4. Any physically debilitating disorders and diagnosed mental retardation, Down’s syndrome, etc.
  5. Children with the history of severe allergies or anaphylactic reactions will be exclued.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00277407

Layout table for location information
United States, California
NAET Pain Clinic
Buena Park, California, United States, 90621
Sponsors and Collaborators
Nambudripad's Allergy Research Foundation
Layout table for investigator information
Principal Investigator: Devi S. Nambudripad, DCLAcPhD NAR Foundation
Additional Information:
Layout table for additonal information Identifier: NCT00277407    
Other Study ID Numbers: MulticlinicalAutism Study
First Posted: January 16, 2006    Key Record Dates
Last Update Posted: May 7, 2007
Last Verified: May 2007
Keywords provided by Nambudripad's Allergy Research Foundation:
Chiropractic procedures
Treatment of Autism by holistic procedures
Food and Vaccination allergy
Additional relevant MeSH terms:
Layout table for MeSH terms
Food Hypersensitivity
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders
Immune System Diseases
Hypersensitivity, Immediate